FDA
-
-
-
-
-
-
-
FDA clears Gain Therapeutics IND for GT-02287 Parkinson's Phase 2
-
-
-
-
-
-
-
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
-
-
-
-
-
-
-
Gain Therapeutics reports biomarker data from Parkinson's trial
-
-
-
-
-
-
-
Gain Therapeutics to Present at Neuroscience 2025
-
-
-
-
-
-
-
Gain Therapeutics Begins Its GT-02287 Phase 1b Extension Study in People with Parkinson’s Disease
-
-
-
-
-
-
-
Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update
-
-
-
-
-
-
-
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
-
329,942 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

